Related Experiment Video
Updated: Jul 27, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
Evolving concepts in prognostic scoring of chronic GvHD
1Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, MN, USA.
Chronic graft-versus-host disease (cGvHD) complicates transplants. New severity scoring aids survival prediction, but integrating older risk factors with current NIH criteria requires further study.
Area of Science:
- Hematology
- Immunology
- Transplantation Medicine
Background:
- Chronic graft-versus-host disease (cGvHD) is a significant post-transplant complication.
- Understanding cGvHD's clinical features and organ involvement is crucial for prognostic assessment.
- Existing risk stratification tools were developed using pre-National Institutes of Health (NIH) consensus data.
Purpose of the Study:
- To evaluate the prognostic significance of cGvHD severity scoring in the post-NIH consensus era.
- To assess the continued relevance of pre-NIH prognostic parameters alongside current severity scores.
- To guide future research in reconciling and integrating diverse cGvHD prognostic models.
Main Methods:
- Analysis of patient data using established cGvHD risk stratification tools.
- Comparison of prognostic parameters from pre-NIH era studies with current NIH criteria.
- Evaluation of independent predictive value of pre-NIH parameters against NIH global severity scores.
Main Results:
- cGvHD global severity scoring has emerged as a powerful prognostic tool post-NIH consensus.
- Interpreting pre-NIH prognostic scoring systems is challenging with redefined NIH criteria.
- Certain pre-NIH prognostic factors retain independent significance for survival prediction.
Conclusions:
- Reconciling pre-NIH prognostic parameters with current NIH criteria is essential.
- Prospective studies using NIH consensus criteria are needed to integrate prognostic scoring systems.
- Accurate prognostic assessment is vital for managing cGvHD and improving patient survival.
More Related Videos
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Heart Failure IV: Classification and Diagnostic Evaluation
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Graves Disease II: Pathophysiology